Late-liver-stage malaria vaccine delivers 89% protection and boosts cellular immunity

Genetically attenuated malaria parasites with extended liver-stage arrest (GA2) showed 89% protection in a clinical trial, surpassing earlier vaccine candidates and highlighting the potential of cellular immunity.

Gut Microbiome Varies by Day and Season

Credit: Dr_Microbe/ iStock The balance of microbes in the human gut varies substantially from morning to night and even more by season, researchers at University

April 28, 2023

Pharmalittle: We’re reading about FDA warnings on CAR-T drugs, a Sanofi deal, and more

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite some cloudy skies hovering overhead. Given that a much-welcomed

January 23, 2024

Opinion | ‘They Had Habituated to Familiar Disgust Elicitors’: What We Heard This Week

“They had habituated to familiar disgust elicitors over a long period.” — Edwin Dalmaijer, DPhil, of the University of Bristol in England, discussing findings that

January 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.